Oblique Therapeutics AB (publ)
559017-4487ActiveInnovative biotech developing breakthrough antibodies using the AbiProt platform.
Biotechnology Companyobliquet.com
Overview
- 10–19
- Employees
- 400–499K SEK
- Revenue
- 2015
- Founded
Key Decision Makers
Lotta Ostler
Chief Operating Officer & Legal
@obliquet.com
Olof Larsson
Chief Scientific Officer
@obliquet.com
Søren Bregenholt
Member of the Board
@obliquet.com
Christer Nordstedt
Chief Executive Officer
@obliquet.com
+7 more contacts in Funnelfeedr
Description
Oblique Therapeutics is an innovative biotechnology company focused on transforming antibody therapeutics. They specialize in developing new antibody medicines, with a primary focus on severe diseases like pain that have large unmet clinical needs. The core of their operation is the pioneering AbiPr...